Bad Pharma

How Drug Companies Mislead Doctors and Harm Patients

Ben Goldacre

15 min read
1m 17s intro

Brief summary

Bad Pharma argues that modern medicine is broken because the evidence used to approve and prescribe drugs is systematically distorted by pharmaceutical companies. By legally hiding negative trial results and manipulating study designs, the industry creates a false picture of drug safety and effectiveness.

Who it's for

This book is for anyone who wants to understand the systemic flaws in how drugs are tested, regulated, and marketed.

Bad Pharma

Audio & text in the Readsome app

Why Medical Evidence is Often Unreliable

Ben Goldacre argues that the foundation of modern medicine is flawed because the evidence used to treat patients is systematically distorted. While we expect doctors to rely on fair tests, many of these tests are designed or analyzed in ways that favor the companies paying for them. This is not a conspiracy theory about secret cures, but a story of how everyday processes of science and regulation have been compromised. When the data used for medical decisions is wrong, the consequences are real: people suffer and die because the treatments they receive are not as effective or safe as they believe.

A major part of the problem is that drug companies are allowed to hide results they do not like. A company might run several trials on a new drug but only publish the ones that show a positive effect. This leaves doctors with a lopsided view of a medicine's true value. This happens across all areas of medicine, from antidepressants to common flu treatments. Because this information is withheld, even the most well-meaning doctors cannot know if the drugs they prescribe are truly the best options for their patients.

The system for approving new drugs also contributes to the issue. Currently, a new drug often only needs to prove it is better than a sugar pill, rather than showing it is better than the treatments already available. This low bar allows less effective drugs to enter the market. Furthermore, regulators often keep the data they do have secret, preventing independent researchers from double-checking the results. This lack of transparency means that serious side effects are sometimes only discovered years after a drug has been in widespread use.

Beyond research and regulation, the way doctors learn about new medicines is heavily influenced by industry spending. Drug companies often spend twice as much on marketing as they do on research. This money funds sales representatives, sponsored educational events, and even academic articles that are secretly written by company employees. Because doctors have little time for formal education after medical school, they often rely on these industry-funded sources to stay current. This creates a cycle where medical practice is shaped more by corporate interests than by objective science.

Full summary available in the Readsome app

Get it on Google PlayDownload on the App Store

About the author

Ben Goldacre

Ben Goldacre is a British physician, academic, and science writer who is the Bennett Professor of Evidence-Based Medicine and Director of the Bennett Institute for Applied Data Science at the University of Oxford. His work focuses on evidence-based medicine, informatics, and epidemiology, and he is known for critically examining the misuse of science and statistics by journalists, politicians, and pharmaceutical companies. Goldacre is a prominent public health campaigner and co-founder of the AllTrials campaign, which advocates for transparency in clinical trial data.

Similar book summaries